Zhang Lin-Jian, Wen Xin, Peng Yang, Hu Wei, Liao Hui, Liu Zi-Cai, Liu Hui-Yu
Department of Rehabilitation Medicine, Yuebei People's Hospital, Shaoguan 512000, Guangdong Province, China.
Department of Rehabilitation Medicine, Shaoguan First People's Hospital, Shaoguan 512000, Guangdong Province, China.
World J Clin Cases. 2024 Aug 26;12(24):5523-5533. doi: 10.12998/wjcc.v12.i24.5523.
The results of existing lower extremity robotics studies are conflicting, and few relevant clinical trials have examined short-term efficacy. In addition, most of the outcome indicators in existing studies are scales, which are not objective enough. We used the combination of objective instrument measurement and scale to explore the short-term efficacy of the lower limb A3 robot, to provide a clinical reference.
To investigate the improvement of lower limb walking ability and balance in stroke treated by A3 lower limb robot.
Sixty stroke patients were recruited prospectively in a hospital and randomized into the A3 group and the control group. They received 30 min of A3 robotics training and 30 min of floor walking training in addition to 30 min of regular rehabilitation training. The training was performed five times a week, once a day, for 2 wk. The -test or non-parametric test was used to compare the three-dimensional gait parameters and balance between the two groups before and after treatment.
The scores of basic activities of daily living, Stroke-Specific Quality of Life Scale, FM balance meter, Fugl-Meyer Assessment scores, Rivermead Mobility Index, Stride speed, Stride length, and Time Up and Go test in the two groups were significantly better than before treatment (19.29 ± 12.15 3.52 ± 4.34; 22.57 ± 17.99 4.07 ± 2.51; 1.21 ± 0.83 0.18 ± 0.40; 3.50 ± 3.80 0.96 ± 2.08; 2.07 ± 1.21 0.41 ± 0.57; 0.89 ± 0.63 0.11 ± 0.32; 12.38 ± 9.00 2.80 ± 3.43; 18.84 ± 11.24 3.80 ± 10.83; 45.12 ± 69.41 8.41 ± 10.20; 29.45 ± 16.62 8.68 ± 10.74; < 0.05). All outcome indicators were significantly better in the A3 group than in the control group, except the area of the balance parameter.
For the short-term treatment of patients with subacute stroke, the addition of A3 robotic walking training to conventional physiotherapy appears to be more effective than the addition of ground-based walking training.
现有下肢机器人研究结果相互矛盾,且相关临床试验较少检验短期疗效。此外,现有研究中的大多数结局指标是量表,客观性不足。我们采用客观仪器测量与量表相结合的方法,探讨下肢A3机器人的短期疗效,以提供临床参考。
研究A3下肢机器人治疗对脑卒中患者下肢步行能力和平衡能力的改善情况。
前瞻性招募一家医院的60例脑卒中患者,随机分为A3组和对照组。除30分钟常规康复训练外,他们分别接受30分钟的A3机器人训练和30分钟的地面步行训练。训练每周进行5次,每天1次,共2周。采用t检验或非参数检验比较两组治疗前后的三维步态参数和平衡能力。
两组患者的日常生活基本活动评分、脑卒中特异性生活质量量表评分、FM平衡仪评分、Fugl-Meyer评估评分、Rivermead运动指数、步速、步长、起立行走测试结果均显著优于治疗前(19.29±12.15 3.52±4.34;22.57±17.99 4.07±2.51;1.21±0.83 0.18±0.40;3.50±3.80 0.96±2.08;2.07±1.21 0.41±0.57;0.89±0.63 0.11±0.32;12.38±9.00 2.80±3.43;18.84±11.24 3.80±10.83;45.12±69.41 8.41±10.20;29.45±16.62 8.68±10.74;P<0.05)。除平衡参数面积外,A3组所有结局指标均显著优于对照组。
对于亚急性脑卒中患者的短期治疗,在传统物理治疗基础上增加A3机器人步行训练似乎比增加地面步行训练更有效。